Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns

The original article was published on 07 July 2020

Nature Reviews Immunology (2020) https://doi.org/10.1038/s41577-020-0389-z Published online 07 July 2020

In the originally published article, a typographical error was introduced during editing. In the statement “In a third study, from Germany, Braun et al.3 reported positive T cell responses against spike peptides in 34% of SARS-CoV-2 seronegative healthy donors (CD4+and CD8+T cells were not distinguished).”, the underlined part was intended to refer to a different study and has now been deleted. A second statement was edited for clarity. “Thiel and colleagues3 reported that the T cell reactivity was highest against a pool of SARS-CoV-2 spike peptides that had higher homology to CCCs, but the difference was not significant.” has been changed to “Thiel and colleagues3 reported that the T cell reactivity was highest against a pool of SARS-CoV-2 spike peptides that had homology to CCCs.”

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Alessandro Sette or Shane Crotty.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sette, A., Crotty, S. Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns. Nat Rev Immunol 20, 644 (2020). https://doi.org/10.1038/s41577-020-00430-w

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing